3i Group plc
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- $25.22
- Today's High:
- $25.71
- Open Price:
- $25.71
- 52W Low:
- $11.0432
- 52W High:
- $25.81
- Prev. Close:
- $25.16
- Volume:
- 935
Company Statistics
- Market Cap.:
- $24.85 billion
- Book Value:
- 17.497
- Revenue TTM:
- $4.75 billion
- Operating Margin TTM:
- 96.91%
- Gross Profit TTM:
- $4.16 billion
- Profit Margin:
- 96.29%
- Return on Assets TTM:
- 18.11%
- Return on Equity TTM:
- 30.9%
Company Profile
3i Group plc had its IPO on under the ticker symbol TGOPF.
The company operates in the Financial Services sector and Asset Management industry. 3i Group plc has a staff strength of 249 employees.
Stock update
Shares of 3i Group plc opened at $25.71 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $25.22 - $25.71, and closed at $25.22.
This is a +0.24% increase from the previous day's closing price.
A total volume of 935 shares were traded at the close of the day’s session.
In the last one week, shares of 3i Group plc have increased by +0.96%.
3i Group plc's Key Ratios
3i Group plc has a market cap of $24.85 billion, indicating a price to book ratio of 0.9031 and a price to sales ratio of 4.2099.
In the last 12-months 3i Group plc’s revenue was $4.75 billion with a gross profit of $4.16 billion and an EBITDA of $4.60 billion. The EBITDA ratio measures 3i Group plc's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, 3i Group plc’s operating margin was 96.91% while its return on assets stood at 18.11% with a return of equity of 30.9%.
In Q3, 3i Group plc’s quarterly earnings growth was a positive 55.4% while revenue growth was a positive 56%.
3i Group plc’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 4.2286
- PEG
- 0
Its diluted EPS in the last 12-months stands at $5.95 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into 3i Group plc’s profitability.
3i Group plc stock is trading at a EV to sales ratio of 0 and a EV to EBITDA ratio of 0. Its price to sales ratio in the trailing 12-months stood at 4.2099.
3i Group plc stock pays annual dividends of $0.53 per share, indicating a yield of 2.66% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $17.82 billion
- Total Liabilities
- $110.00 million
- Operating Cash Flow
- $0
- Capital Expenditure
- $0
- Dividend Payout Ratio
- 0%
3i Group plc ended 2024 with $17.82 billion in total assets and $0 in total liabilities. Its intangible assets were valued at $17.82 billion while shareholder equity stood at $16.84 billion.
3i Group plc ended 2024 with $0 in deferred long-term liabilities, $110.00 million in other current liabilities, 719000000.00 in common stock, $0 in retained earnings and $0 in goodwill. Its cash balance stood at $162.00 million and cash and short-term investments were $162.00 million. The company’s total short-term debt was $0 while long-term debt stood at $0.
3i Group plc’s total current assets stands at $205.00 million while long-term investments were $17.48 billion and short-term investments were $0. Its net receivables were $43.00 million compared to accounts payable of $110.00 million and inventory worth $0.
In 2024, 3i Group plc's operating cash flow was $0 while its capital expenditure stood at $0.
Comparatively, 3i Group plc paid $0 in dividends in 2024.
Other key metrics
- Current Trading Price
- $25.22
- 52-Week High
- $25.81
- 52-Week Low
- $11.0432
- Analyst Target Price
- $
3i Group plc stock is currently trading at $25.22 per share. It touched a 52-week high of $25.81 and a 52-week low of $25.81. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $24.68 and 200-day moving average was $20.43 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 354.3% of the company’s stock are held by insiders while 5520.5% are held by institutions.
Frequently Asked Questions About 3i Group plc
Similar Industry Stocks (Asset Management)
Most Active
Top Gainers
Top Losers
About
3i Group plc is a private equity firm specializing in mature companies, growth capital, middle markets, infrastructure, and management leveraged buyouts and buy-ins. The firm also provides infrastructure financing and debt management. For debt management, it invests in senior and mezzanine corporate debt in typically large and private companies in United Kingdom, Europe, Asia, and North America. It makes private equity investments in business and technology services, financial services, consumer, healthcare, consumption and distribution, media and telecom, renewable energy, wind, and industrial technology sector. Within business and technology services, the firm seeks to invest in sub sectors such as testing, inspection and certification; intelligent outsourcing, BPO and consultancy; human capital including staffing, governance, risk and compliance, services to pharmaceutical companies, vertical application software, education and training businesses; facilities management; support services to industrial sectors such as oil and gas and utilities; human resources outsourcing and advising; recruitment; logistics and infrastructure support services including distribution, waste, and rental. In the consumer sector, it focuses on, multi-unit roll out, omni-channel propositions, niche branded consumer goods, polarization, health and wellness, ageing population, millennials, consumer goods; e-commerce; retail; food and drinks; and leisure. In the healthcare sector, the firm focuses on outsourced medical device manufacturing & services, outsourced pharmaceutical manufacturing & services, bioprocessing supply chain, life science tools and diagnostics, wellness & consumer health products, pharmaceuticals and biotechnology including specialty pharma, generics / OTC, drug delivery, and animal health; healthcare Services including activities such as elderly and specialty care, including caring for people in their own homes, in hospital and in community facilities, as well as operational services such as outsourced support, cl